Select Publications

Preprints

Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2019, Anti-Thymocyte Globulin for Patients Undergoing Hematopoietic Cell Transplantation from Unrelated Donors: A Randomized, Controlled, Open-Label, Phase 3, Multicentre Trial from Cell Therapy Transplant Canada, http://dx.doi.org/10.2139/ssrn.3429920

Ponraj R; Trahair T; Enjeti A; Fleming S; Kwan J; Moore J; Harvey M; Osborn M; Brown C; Anazodo A; D'Rozario J; Warburton P; White D; Venn N; Law T; Henderson M; Stevenson W; Sutton R; Greenwood M, Real-world outcomes of acute lymphoblastic leukaemia in AYA and older adults: impact of molecular MRD on risk-adapted therapy and allogeneic transplantation, http://dx.doi.org/10.21203/rs.3.rs-10880284/v1

Gration B; Chai RC; Young SG; Sergio CM; Skorokhodova E; Smith JT; Castro-Martinez A; Bray A; Lin X; Yan C; Kao J; Perram J; Lai S; Lau L; Weilbaecher KN; Moore J; Pocock N; Chaffer CL; Center J; Phan TG; McCaughan G; Croucher PI, Romosozumab Safely Restores Bone Mass in Multiple Myeloma via Osteoblast Reprogramming: A Phase IIa Study, http://dx.doi.org/10.64898/2026.07.02.26357196


Back to profile page